May 8, 2024 · Form 4 insider transaction
Bluestone Jeffrey bought 2,310 shares of Gilead Sciences, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.; 100% of the restricted stock units vested immediately upon the grant date of May 8, 2024.